Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Staar Surgical Co (STAA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 417,690
  • Shares Outstanding, K 40,950
  • Annual Sales, $ 82,430 K
  • Annual Income, $ -12,130 K
  • 36-Month Beta 1.30
  • Price/Sales 5.07
  • Price/Cash Flow 0.00
  • Price/Book 11.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.85 +3.55%
on 07/07/17
11.05 -7.69%
on 06/30/17
-0.45 (-4.23%)
since 06/27/17
3-Month
8.95 +13.97%
on 06/08/17
11.05 -7.69%
on 06/30/17
-0.45 (-4.23%)
since 04/27/17
52-Week
6.51 +56.68%
on 07/28/16
11.50 -11.30%
on 12/23/16
+3.57 (+53.85%)
since 07/27/16

Most Recent Stories

More News
STAAR Surgical to Report Second Quarter Results on August 2, 2017

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results...

STAA : 10.20 (unch)
STAAR Surgical Reports First Quarter 2017 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the first quarter...

STAA : 10.20 (unch)
Investor Network: STAAR Surgical Company to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 3, 2017 / STAAR Surgical Company (NASDAQ: STAA) will be discussing their earnings results in their Q1 Earnings Call to be held May 3, 2017 at 4:30 PM Eastern Time.

STAA : 10.20 (unch)
STAAR Surgical to Report First Quarter Results on May 3, 2017

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results...

STAA : 10.20 (unch)
STAAR Surgical Names Deborah Andrews Interim CFO

STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that Steve Brown has resigned his...

STAA : 10.20 (unch)
STAAR Surgical Reports Fourth Quarter 2016 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the fourth quarter...

STAA : 10.20 (unch)
STAAR Surgical to Report Fourth Quarter Results on March 2, 2017

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results...

STAA : 10.20 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

See More

Support & Resistance

2nd Resistance Point 10.63
1st Resistance Point 10.42
Last Price 10.20
1st Support Level 9.97
2nd Support Level 9.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.